Sino Biopharmaceutical Limited
SBMFF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$12B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $12.00 Billion |
|---|---|
| Enterprise Value | $14.29 Billion |
| Annual dividend | $0.01 |
| Dividend yield | 2.40% |
| Earnings per Share | $0.13 |
| Beta | 0.61 |
| Outstanding Shares | 18,048,524,000 |
Return
| Return on Equity | 7.34% |
|---|---|
| Return on Assets | 2.87% |
| Return on Invested Capital | 16.90% |
Valuation & Multiples
| P/E Ratio | 31.92 |
|---|---|
| PEG | 2351.16 |
| Price to Sales | 0.67 |
| Price to Book Ratio | 0.33 |
| Enterprise Value to Revenue | 0.42 |
| Enterprise Value to EBIT | 1.51 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 1.2 |
| Debt to Equity | 0.53 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
$0.02
Consensus analyst estimateRevenue Estimate
$2.84 B
Consensus analyst estimateNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
$0.01
Consensus analyst estimateRevenue Estimate
$2.50 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Sino Biopharmaceutical Ltd.
22,838 employees
CEO: Ping Tse
Sino Biopharmaceutical Limited, an investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China. It operates through three segments: Modernised Chinese Medicines and Che...